• Proteoform-Specific Drug Interactions in Native Membranes

  2026-07-23

  This study pioneers in situ characterization of proteoform-specific protein–drug interactions within native cell membranes, uncovering how post-translational modifications and alternative splicing directly influence drug binding and off-target effects. These findings provide a crucial framework for developing more precise and effective therapeutics, especially in the context of cGMP-specific phosphodiesterase type 5 inhibitors.

• Distinct Vascular Effects of JAK Inhibitors in Inflammatory

  2026-07-23

  This study systematically compares the vascular effects of multiple JAK inhibitors, including tofacitinib citrate, on endothelial inflammation and apoptosis under conditions simulating rheumatoid arthritis-associated cardiovascular risk. The findings reveal nuanced differences in cytokine modulation and prothrombotic signaling, informing both immune regulation research and safety assessment of JAK-STAT pathway inhibitors.

• TP53-Dependent Antitumor Effects of DHODH Inhibition in NPC

  2026-07-22

  Dong et al. reveal that targeting dihydroorotate dehydrogenase (DHODH) in nasopharyngeal carcinoma (NPC) cells induces TP53-dependent antitumor responses. Their work highlights the clinical potential of DHODH inhibitors for NPC and underscores the importance of nucleic acid metabolism in tumor progression.

• Azithromycin in Antimicrobial Resistance Studies: Mechanisms

  2026-07-22

  Explore the molecular mechanisms and advanced research protocols using Azithromycin, a 15-membered macrolide antibiotic, with a focus on emerging antimicrobial resistance and assay optimization. Discover how recent findings inform best practices in bacterial infection research.

• Optimizing In Vitro RNA: Mechanistic Insights & Translationa

  2026-07-21

  Explore how advanced polyadenylation strategies, specifically the HyperScribe™ Poly (A) Tailing Kit, unlock new possibilities for mRNA stability, translation efficiency, and experimental reliability in translational research. The article bridges mechanistic understanding of E. coli Poly (A) Polymerase function with strategic guidance for researchers, referencing current literature and highlighting the broader impact on molecular biology and therapeutic innovation.

• Phenylmethanesulfonyl Fluoride (PMSF): Mechanism and Utility

  2026-07-21

  Phenylmethanesulfonyl fluoride (PMSF) is a well-characterized irreversible serine protease inhibitor used to prevent proteolytic degradation during protein extraction. PMSF acts by covalently modifying serine residues at enzyme active sites, ensuring protein integrity in workflows such as Western blot preparation. Its specificity, handling requirements, and application boundaries are essential for reliable research outcomes.

• GSK2606414: Advanced PERK Inhibitor Workflows for ER Stress

  2026-07-20

  GSK2606414 delivers unmatched selectivity and potency for dissecting PERK-driven ER stress pathways. This article unpacks practical, scenario-driven workflows, troubleshooting insights, and applied guidance—empowering researchers to push boundaries in disease modeling and unfolded protein response modulation.

• Oridonin Suppresses TAA-Induced Osteoclastogenesis via NF-κB

  2026-07-20

  This study demonstrates that oridonin effectively inhibits thioacetamide-induced osteoclast differentiation by targeting the MAPK and NF-κB pathways while promoting osteoblastogenesis via BMP-2/RUNX2 signaling. The findings provide mechanistic clarity and experimental evidence for oridonin's dual role in modulating bone formation and resorption, offering promising leads for osteoporosis therapies.

• Deferasirox: Redefining Iron Chelation in Cancer Research

  2026-07-19

  This thought-leadership article explores the mechanistic and translational frontier of Deferasirox as an oral iron chelator, highlighting novel insights into ferroptosis resistance in hepatocellular carcinoma and offering strategic, evidence-based guidance for translational researchers. Building on recent breakthroughs in the METTL16-SENP3-LTF axis and competitive insights, the article positions Deferasirox as an indispensable tool for decoding tumor iron metabolism and advancing targeted therapies.

• GCG Disrupts SARS-CoV-2 N Protein Phase Separation to Inhibi

  2026-07-18

  A recent study revealed that the SARS-CoV-2 nucleocapsid (N) protein undergoes RNA-triggered liquid–liquid phase separation (LLPS), a process essential for viral replication. The green tea polyphenol (-)-gallocatechin gallate (GCG) was found to disrupt this condensation, inhibiting viral replication and suggesting a novel antiviral strategy.

• ABT-263 (Navitoclax) in Engineered Cell Lines: Redefining Ap

  2026-07-17

  Explore how ABT-263 (Navitoclax) empowers advanced apoptosis assays and cancer biology using engineered cell models. This in-depth review uncovers mechanistic, methodological, and translational innovations for precision oncology research.

• CX-4945 (Silmitasertib): Selective CK2 Inhibition in Cancer

  2026-07-17

  CX-4945 (Silmitasertib) is a potent, selective CK2 inhibitor with nanomolar activity. It arrests cancer cell cycles and induces apoptosis via PI3K/Akt pathway suppression. Evidence supports its role in limiting cancer stemness and chemoresistance.

• Oligo (dT) 25 Beads: Technical Guide for Eukaryotic mRNA Iso

  2026-07-16

  Oligo (dT) 25 Beads enable selective isolation of polyA+ eukaryotic mRNA from total RNA or lysed cells and tissues, supporting workflows that demand high mRNA purity and integrity. They are not designed for prokaryotic RNA or applications where non-polyadenylated transcripts are the main target. Proper storage and workflow adherence are essential for optimal performance.

• Mechanistic Insights: EZ Cap™ Firefly Luciferase mRNA in Imm

  2026-07-16

  Explore how EZ Cap™ Firefly Luciferase mRNA with Cap 1 structure enables robust, immune-evasive bioluminescent reporting. This article uniquely examines mechanistic innovations, innate immunity, and advanced assay optimization for molecular biology applications.

• Carbapenemase Genes and Resistance Dynamics in CREC in Guang

  2026-07-15

  This study investigates the prevalence, genetic contexts, and transmission dynamics of carbapenemase-encoding genes among carbapenem-resistant Enterobacter cloacae (CREC) isolates collected from teaching hospitals in Guangdong, China, during the COVID-19 pandemic. The findings reveal a high rate of multidrug resistance, dominant plasmid-borne blaNDM-1 genes, and efficient horizontal gene transfer, with significant epidemiological implications for infection control and antibiotic stewardship.

16331 records 1/1089 page Next 12345 下5页 Last page